Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0000899243-20-034355

Director bought 3,000,000 shares at $20.00 ($60,000,000)

  • Director acquired 10,468,907 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
THIEL PETER Director 2020-12-15 Conversion +3,811,260 4,702,780 I
THIEL PETER Director 2020-12-15 Conversion +2,477,100 7,179,880 I
THIEL PETER Director 2020-12-15 Purchase +3,000,000 $20.00 $60,000,000 10,179,880 I
THIEL PETER Director 2020-12-15 Conversion +3,343,240 3,343,240 I
THIEL PETER Director 2020-12-15 Conversion +401,050 401,050 I
THIEL PETER Director 2020-12-15 Conversion +29,240 29,240 I
THIEL PETER Director 2020-12-15 Conversion +382,357 382,357 I
THIEL PETER Director 2020-12-15 Conversion +24,660 24,660 I
Derivatives
THIEL PETER Director 2020-12-11 Grant or award · Convertible Note +0 $30,430,000.00 $0 I
THIEL PETER Director 2020-12-11 Grant or award · Convertible Note +0 $4,697,050.00 $0 I
THIEL PETER Director 2020-12-11 Grant or award · Convertible Note +0 $302,950.00 $0 I
THIEL PETER Director 2020-12-15 Conversion · Series A2 Preferred Shares −381,126 0 I
THIEL PETER Director 2020-12-15 Conversion · Series A2 Preferred Shares −334,324 0 I
THIEL PETER Director 2020-12-15 Conversion · Series A2 Preferred Shares −40,105 0 I
THIEL PETER Director 2020-12-15 Conversion · Series A2 Preferred Shares −2,924 0 I
THIEL PETER Director 2020-12-15 Conversion · Convertible Note −0 0 I
THIEL PETER Director 2020-12-15 Conversion · Convertible Note −0 0 I
THIEL PETER Director 2020-12-15 Conversion · Convertible Note −0 0 I
Open-market purchases · 3,000,000 sh · avg $20.00 · $60,000,000
Loading xslF345X03/doc4.xml…